Abstract Search

ea0029p1444 | Pituitary Clinical | ICEECE2012

Evaluation of cardiovascular risk factors and metabolic profile in hyperprolactinemic subjects

Sayki Arslan M. , Sahin M. , Esra T. , Cakir Ozkaya E. , Bozkurt Colak N. , Karbek B. , Ozturk Unsal I. , Ucan B. , Gungunes A. , Cakal E. , Ozbek M. , Topaloglu O. , Demirci T. , Karakose M. , Caliskan M. , Ginis Z. , Delibasi T.

Objective: Hyperprolactinemia has been reported to be associated with abnormalities of glucose metabolism and cardiovascular inflammatory markers. However, the metabolic effects of high prolactin levels are not adequately clarified. The aims of this study were to evaluate the effects of hyperprolactinemia on endothelial function, insulin sensitivity and inflammatory markers in prolactinoma diagnosed subjects.Methods: In total, 58 hyperprolactinemic subje...

1 shares

ea0029p1725 | Thyroid (non-cancer) | ICEECE2012

Serum nesfatin-1 levels in overt and subclinical hyperthyroidism

Gungunes A. , Ginis Z. , Demirci T. , Cakir E. , Karbek B. , Sayki Arslan M. , Ozturk Unsal I. , Tutal Akkaya E. , Ucan B. , Cakal E. , Gultuna Ozguclu S. , Ozbek M. , Sahin M. , Topaloglu O. , Delibasi T.

Objective: Nesfatin-1, was recently discovered in the brain which is derived from nucleobindin2 (NUCB2). Central and peripheral administration of nesfatin-1, inhibits food intake, dose-dependently. Hyperthyroid patients have increased appetite and food intake with a craving for carbohydrate-rich food, at the beginning of disease, but the physiological mechanisms underlying this behavior is not known exactly. In this study, we investigated whether nesfatin-1 is involved in the ...

0 shares

Endocrine Abstracts

Evaluation of cardiovascular risk factors and metabolic profile in hyperprolactinemic subjects

Serum nesfatin-1 levels in overt and subclinical hyperthyroidism

BiosciAbstracts